Yanying Miao Selected Research

Gliosis

1/2023	Activation of retinal glial cells contributes to the degeneration of ganglion cells in experimental glaucoma.
1/2023	EphA4/ephrinA3 reverse signaling induced Müller cell gliosis and production of pro-inflammatory cytokines in experimental glaucoma.
10/2020	Tumor necrosis factor-alpha aggravates gliosis and inflammation of activated retinal Müller cells.
10/2018	EphrinB/EphB forward signaling in Müller cells causes apoptosis of retinal ganglion cells by increasing tumor necrosis factor alpha production in rat experimental glaucomatous model.
1/2018	Dopamine D1 receptor-mediated upregulation of BKCa currents modifies Müller cell gliosis in a rat chronic ocular hypertension model.
12/2017	Ghrelin Attenuates Retinal Neuronal Autophagy and Apoptosis in an Experimental Rat Glaucoma Model.
1/2017	Involvement of the MEK-ERK/p38-CREB/c-fos signaling pathway in Kir channel inhibition-induced rat retinal Müller cell gliosis.
2/2015	Group I metabotropic glutamate receptor agonist DHPG modulates Kir4.1 protein and mRNA in cultured rat retinal Müller cells.
9/2012	Group I mGluR-mediated inhibition of Kir channels contributes to retinal Müller cell gliosis in a rat chronic ocular hypertension model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanying Miao Research Topics

Disease

13	Glaucoma 03/2023 - 08/2011
9	Gliosis 01/2023 - 09/2012
7	Ocular Hypertension (Glaucoma, Suspect) 01/2023 - 09/2012
3	Ganglion Cysts (Ganglion) 01/2023 - 12/2017
2	Inflammation (Inflammations) 10/2020 - 02/2014
2	Reperfusion Injury 06/2014 - 08/2007
1	Neoplasms (Cancer) 01/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021
1	Blindness (Hysterical Blindness) 12/2021
1	Hypertension (High Blood Pressure) 12/2017
1	Body Weight (Weight, Body) 06/2014
1	Infarction (Infarctions) 06/2014
1	Brain Ischemia (Cerebral Ischemia) 06/2014
1	Brain Edema (Cerebral Edema) 06/2014
1	Acidosis 02/2014
1	Vascular System Injuries 02/2014
1	Stroke (Strokes) 02/2014
1	Nervous System Diseases (Neurological Disorders) 08/2011
1	Osteoporotic Fractures 05/2009
1	Tauopathies 04/2009
1	Alzheimer Disease (Alzheimer's Disease) 04/2009
1	Ischemia 08/2007
1	Pathologic Processes 07/2007
1	AIDS-Related Complex (ARC) 05/2006

Drug/Important Bio-Agent (IBA)

13	Retinaldehyde (Retinal)IBA 01/2023 - 09/2012
6	Glial Fibrillary Acidic ProteinIBA 01/2023 - 09/2012
4	Glutamic Acid (Glutamate)FDA Link 03/2023 - 08/2007
4	GhrelinIBA 12/2017 - 05/2006
3	CytokinesIBA 01/2023 - 08/2021
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2021 - 10/2018
3	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 10/2020 - 02/2015
3	Neuroprotective AgentsIBA 12/2017 - 06/2014
2	Proteins (Proteins, Gene)FDA Link 11/2020 - 10/2018
2	3,4-dihydroxyphenylglycolIBA 10/2020 - 02/2015
2	Messenger RNA (mRNA)IBA 10/2018 - 02/2015
2	Kcnj10 (channel)IBA 02/2015 - 09/2012
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 03/2023
1	Connexin 43 (Connexin43)IBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023
1	ChemokinesIBA 01/2023
1	PurinesIBA 01/2023
1	InterleukinsIBA 01/2023
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2023
1	Type I Tumor Necrosis Factor ReceptorsIBA 08/2021
1	iberiotoxinIBA 01/2018
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	Sirolimus (Rapamycin)FDA Link 06/2014
1	Evans Blue (Blue, Evans)FDA Link 06/2014
1	Free RadicalsIBA 02/2014
1	Biomarkers (Surrogate Marker)IBA 02/2014
1	LipidsIBA 02/2014
1	CalciumIBA 02/2014
1	Cyclin-Dependent Kinase 5IBA 08/2011
1	Vitamin D FDA LinkGeneric 05/2009
1	Cholecalciferol (Vitamin D3)FDA Link 05/2009
1	1,25-dihydroxyvitamin DIBA 05/2009
1	Caspase 3 (Caspase-3)IBA 04/2009
1	N-Methylaspartate (NMDA)IBA 08/2007

Therapy/Procedure

3	Intravitreal Injections 01/2023 - 01/2018
1	Therapeutics 02/2014